Corient Private Wealth’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Buy
4,882
+1,488
+44% +$626K ﹤0.01% 1319
2026
Q1
$1.28M Sell
3,394
-817
-19% -$350K ﹤0.01% 1503
2025
Q4
$1.8M Sell
4,211
-1,356
-24% -$590K ﹤0.01% 1211
2025
Q3
$745K Buy
5,567
+3,316
+147% +$1.5M ﹤0.01% 1575
2025
Q2
$1.1M Buy
2,251
+114
+5% +$65K ﹤0.01% 1320
2025
Q1
$1.31M Sell
2,137
-151
-7% -$85.8K ﹤0.01% 1164
2024
Q4
$1.21M Sell
2,288
-426
-16% -$240K ﹤0.01% 1232
2024
Q3
$1.63M Buy
2,714
+31
+1% +$17.6K ﹤0.01% 1190
2024
Q2
$1.46M Sell
2,683
-24
-0.9% -$13.7K ﹤0.01% 1176
2024
Q1
$1.74M Sell
2,707
-34
-1% -$20.7K ﹤0.01% 1087
2023
Q4
$1.6M Buy
2,741
+200
+8% +$112K ﹤0.01% 1103
2023
Q3
$1.32M Buy
2,541
+729
+40% +$379K ﹤0.01% 1092
2023
Q2
$982K Sell
1,812
-7
-0.4% -$3.83K ﹤0.01% 1157
2023
Q1
$978K Buy
1,819
+1,011
+125% +$516K ﹤0.01% 1096
2022
Q4
$412K Buy
+808
New +$393K ﹤0.01% 1212

Other funds holding CHE

Corient Private Wealth's CHE Position: Q2 2026 in Review

Corient Private Wealth increased its Chemed (CHE) stake by 44% in Q2 2026, buying an estimated $626K and bringing the position to 4,882 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

Corient Private Wealth first reported a position in CHE in Q4 2022 and has held it in 15 quarters since. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Corient Private Wealth held 4,882 shares of Chemed worth $2.27M as of Q2 2026.
  • Corient Private Wealth bought 1,488 Chemed shares in Q2 2026, an estimated $626K.
  • Chemed made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1319 holding.
  • Corient Private Wealth first reported a position in Chemed in Q4 2022 and has held it in 15 quarters since.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.